Active Pharmaceutical Ingredients Market 2018 Global Analysis, Industry Demand, Trends, Size, Opportunities, Forecast 2023


Wiseguyreports.Com Adds “Active Pharmaceutical Ingredients – Global  Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022”

The Global Active Pharmaceutical Ingredients market is expected to grow from $129.12 billion in 2015 to reach $198.8 billion by 2022 with a CAGR of 6.4%. Patent expiration of prominent drugs, government initiatives, regional penetration and increasing aged population are some of the factors that are driving the market growth. Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth.

Click here for a sample report @

Generic/Non- Branded segment witnessed the largest market share during the forecast period due to rising healthcare costs, government prominence on generics for dropping healthcare costs, and decreasing pipelines of global pharmaceutical products. Asia Pacific is expected to be highest market share during the forecast period due to low operation costs and high investments in medical research. Moreover, the high cost of skilled labour and energy are the most significant factors that enforced European market to move its base to developing countries, such as India and China.

Some of the key players in global Active Pharmaceutical Ingredients market include Bioniche Animal Health (Canada), Boehringer Ingelheim (Germany), Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Bayer Healthcare (Germany), Merial Inc. (Sanofi) (France), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Ceva Animal Health, Inc., Dr. Reddy’s Laboratories Ltd., Novartis International AG, Ranbaxy Laboratories, Virbac, Zoetis (U.S.), Pfizer, Inc, Aurobindo Pharma Ltd., and Heska Co. (U.S.)

Types of API Covered:
• Synthetic chemical API
o Branded/ Innovative
o Generic/Non- Branded
• Biological API
o Biotech
o Biosimilar
• High potency active pharmaceutical ingredients(HPAPI)
Types of Manufacturing Covered:
• Captive (or in-house) manufacturing
• Contract manufacturing

Therapeutic Applications Covered:
• Anti-Infectives
• Cardiovascular and hematopoietic system
• CNS and Neurological Disorders
• Diabetes
• Endocrinology
• Gastrointestinal disorder
• Hormonal-related disorder
• Metabolic disorder
• Musculoskeletal disorder
• Nephrology
• Oncology
• Ophthalmology
• Orthopedic Disorders
• Pulmonology
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements


At any Query @

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions


7 Global Active Pharmaceutical Ingredients Market, By Therapeutic Application
7.1 Introduction
7.2 Anti-Infectives
7.3 Cardiovascular and hematopoietic system
7.4 CNS and Neurological Disorders
7.5 Diabetes
7.6 Endocrinology
7.7 Gastrointestinal disorder
7.8 Hormonal-related disorder
7.9 Metabolic disorder
7.10 Musculoskeletal disorder
7.11 Nephrology
7.12 Oncology
7.13 Ophthalmology
7.14 Orthopedic Disorders
7.15 Pulmonology

8 Global Active Pharmaceutical Ingredients Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Bioniche Animal Health (Canada)
10.2 Boehringer Ingelheim (Germany)
10.3 Sun Pharmaceutical Industries Ltd.
10.4 Teva Pharmaceutical Industries Limited
10.5 Bayer Healthcare (Germany)
10.6 Merial Inc. (Sanofi) (France)
10.7 Elanco Animal Health (U.S.)
10.8 Merck Animal Health (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Dr. Reddy’s Laboratories Ltd.
10.11 Novartis International AG
10.12 Ranbaxy Laboratories
10.13 Virbac
10.14 Zoetis (U.S.)
10.15 Pfizer, Inc
10.16 Aurobindo Pharma Ltd.
10.17 Heska Co. (U.S.)


Contact info

Contact Us: [email protected]

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

The post Active Pharmaceutical Ingredients Market 2018 Global Analysis, Industry Demand, Trends, Size, Opportunities, Forecast 2023 appeared first on Herald Keeper.

Add Comment